Impact Factor
3.84
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.94
460 total citations
h5-index
27
h5 depth signal
Cited share
88.0%
73 of 83
Total citations
460
Citation footprint
Metric signal
4.80
External metric anchor
Self-citation
3.5%
16 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
269
Netherlands
115
China
80
United States
64
Australia
58
Citing Fields of Research
Allergies
466
Respiratory Support
135
Patient Care
67
Health Education & Remote Healthcare
53
Lung Cancer
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
748
Articles tracked across the journal lifetime
Indexed publication set
83
73 cited publications
Last 12 months
117
9.8 publications/month
Open access share
100.0%
117 OA publications in the last year
Leading citing country
United Kingdom
269 citing publications
Leading citing field
Allergies
466 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v24, May 2014-
v24, May 2014-
Active Coverage
Research Focus & Classification
Indexed Subjects
Allergies
Issuing & Sponsoring Bodies
issuing body
Primary Care Respiratory Society UK
issuing body
International Primary Care Respiratory Group
Broad Categories
Primary Health Care
Pulmonary Medicine
Allergies
MeSH Descriptors
Asthma
Primary Health Care
Respiratory Therapy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1038/s41533-026-00561-y
Open DOI
A mixed-methods assessment of inhaler sustainability across the respiratory care pathway
Inhalers are central to asthma and COPD care but contribute to the environmental impact of respiratory services. Sustainability efforts have often focused on reducing device-level carbon emissions, particularly through switching from pre...
04
DOI 10.1038/s41533-026-00572-9
Open DOI
Healthcare professionals’ perspectives and experiences of relief treatment for mild asthma in UK primary care settings
In 2024, the UK British Thoracic Society/National Institute for Health and Care Excellence/Scottish Intercollegiate Guidelines Network (BTS/NICE/SIGN) guidelines introduced a major change in asthma management, recommending inhaled cortic...
05
06
DOI 10.1038/s41533-026-00570-x
Open DOI
Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease
Post-COVID-19 symptoms are common following COVID-19, but risk factors of persistent symptoms in patients with asthma and chronic obstructive lung disease (COPD) remain unclear. We aimed to assess the frequency and risk factors of post-C...
07
DOI 10.1038/s41533-026-00566-7
Open DOI
Ecosocial environments and chronic lower respiratory disease mortality: a nationwide ecological study
08
DOI 10.1038/s41533-026-00567-6
Open DOI
Pulmonary rehabilitation in a humanitarian context: a feasibility study from Cox’s Bazar, Bangladesh
Pulmonary rehabilitation (PR) is an effective intervention for chronic respiratory diseases (CRD), but its feasibility in low-resource and humanitarian settings remains underexplored. We evaluated a culturally adapted PR programme delive...
09
10
DOI 10.1038/s41533-026-00563-w
Open DOI
Allergic rhinitis in primary care: Navigating diagnostic uncertainty, treatment failure and referral
Allergic rhinitis is usually first recognised and treated in primary care, where decisions often precede allergen testing or specialist assessment. The challenge is not simply identifying classic allergic symptoms, but distinguishing cli...